Join APBioNet      Join AMBIS     Join ISCB      Key Dates     Register Now      

Index
General Information
Program
Keynotes
Committees
Key dates
Submissions/Guidelines
Registration
Venue
Hotels
Venue
Sponsors/Exhibitors
Sponsor Information
Contact Us
Uniquely Singapore

Nobel Laureate Keynote
Robert Huber, Max-Planck Institut f. Biochemistry, Germany.

A-STAR NUS NTU

ISCB

APB
AMBIS

PUBLICATION PROCESS

Publication Procedure

Dear Authors,
Submissions have been completed and closed.
Reviews have been done.
Successful authors have been notified by the Editors.
Payment collection for onward transmission to the Publisher, BioMed Central is now in progress.
Please make your payment from the hyperlinks below.
If you have any queries, please do not hesitate to contact incob09 at apbionet.org
Thank you for selecting InCoB to be your conference of choice. We deeply appreciate your continuing support.

The Editors
July 2009

Publication Payment

You may be pleased to note that we have negotiated a good rate of publication charges with the kind cooperation of BioMed Central. Payment of publications are offered to you at discount from the official listed price at BMC.

Please make your payments promptly and in good time as bank transfers take time and we need to make full payment to BMC before they will publish on the stated publication date. Please choose one of the following modes of payment convenient to you. Due to exchange rates and bank and vendor charges, the modes of payment different slightly in the amount payable.

  • Pay via PayPal (GBP 850): PayPal Payment
  • Pay via Singapore E-Nets (SGD 2020): E-Nets Payment
  • Pay Offline via Postal Bank Draft or Bank Wire Transfer (SGD 2020): Pay Offline

    SUBMISSIONS CLOSED/GUIDELINES

    Submission dates

    Date Description
    Feb 15 Submission begins
    Apr 30 May 15 My 25 Full paper submission deadline at 23:59 GMT
    May 15 May 25 Tutorial, highlights, technology, poster abstract submission deadline at 23:59 GMT

    Click here for important notification dates.

    Submission procedure

    We invite you to participate in the following sessions:

    All submissions to InCoB 2009 is through the EasyChair conference system. The submission process requires registration to create an EasyChair account prior to submission. Submitted full Papers are automatically considered for publication in special supplements of BMC Genomics (Impact Factor 4.18) and Bioinformation.

    EasyChair submission page: http://www.easychair.org/conferences/?conf=incob2009

    Login for programme committee: http://www.easychair.org/conferences/?conf=incob2009

    Posters

    We solicit high-quality research posters in any aspect of bioinformatics and computational biology conveying a scientific result. At least one author of each selected poster must register for InCoB2009. Furthermore, a single registration can cover only only oral presentation and one poster presentation or two poster presentations.

    You must submit within one document (PDF format), a title and two versions of your poster abstract: a 50-word abstract that will be printed in the conference program and a one-page abstract (~250 words) that will be posted on the conference web site.

    Please refer here for list of accepted posters.

    Tutorials

    InCoB2009 will feature a limited number of half-day tutorials on 7-8 Sept., on either well-established or new and emerging, cutting-edge topics, relevant to bioinformatics. Lecture materials and instruction notes are required from the presenter, who will be a provided a free InCoB2009. registration.

    You must submit within one document (PDF format), two versions of your tutorial abstract: a 50-word abstract that will be printed in the conference program and a one-page abstract (~250 words) that will be posted on the conference web site.

    Highlights track

    We invite abstracts on full papers that have been published or accepted for publication (please provide us email acceptance or online version) after Septmeber 1, 2008. A group of experts will select abstracts to be presented at the meeting, considering the impact of the work on the field, the likelihood that the study would be of interest to the InCoB audience and the relevance of the research to bioinformatics and application to molecular and medical sciences. Presenters must register for InCoB2009.

    Technology track

    The Technology Track provides an opportunity for showcasing

    • bioinformatics resources
    • software or hardware developments relevant to the community
    Databases, web sevices, software and recently available hardware tools are some suggestions for this track.

    Presenters must register for InCoB2009.

    Full papers

    A single PDF file with all tables and figures is to be submitted to EasyChair for review.

    Full papers submitted to InCoB 2009 should be divided into the following sections:

    Title page
    This should include: manuscript title, which should give an accurate, clear and concise description of the reported work, avoiding abbreviations; and the full names, institutional addresses, and e-mail addresses for all authors. The corresponding author should also be indicated.

    Abstract
    The abstract of the manuscript should not exceed 350 words and must be structured into separate sections: Background, the context and purpose of the study; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract.

    Background
    The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. The section should end with a very brief statement of what is being reported in the article.

    Results and Discussion
    The Results and Discussion may be combined into a single section or presented separately. They may also be divided into subsections with short, informative headings.

    Conclusions
    This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

    Methods
    This should be divided into subsections if several methods are described.

    List of abbreviations
    If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the authors' contributions and acknowledgements.

    Authors' contributions
    In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.

    An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.

    All contributors who do not meet the criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.

    Authors' information
    You may choose to use this section to include any relevant information about the author(s) that may aid the readerís interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.

    Acknowledgements
    Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.

    Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

    Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

    References
    All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

    Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are.

    Figures
    Figures should be placed sequentially at the end of the manuscript file, with one figure per page.

    Figure legends
    The legends should be included in the main manuscript text file immediately following the references, rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words.

    Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.

    Tables and captions
    Tables should be in the main manuscript text, with one table per page numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.

    Additional files
    Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the final, published form of the article, but a link will be provided to the files as supplied by the author. A compress .zip file of the additional materials can be uploaded to EasyChair.

    Accepted Articles

    For submissions accepted to the BMC Genomics special issue on InCoB 2009, detailed formatting instructions, under "Preparing main manuscript text", are available at http://www.biomedcentral.com/bmcgenomics/ifora/.

    For submissions accepted to the Bioinformation special issue on InCoB 2009, detailed formatting instructions, under "Author Guidelines", are available at http://www.bioinformation.net/journal/instructions.htm.